Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Difluoromethylornithine (DFMO), an inhibitor of
ornithine decarboxylase
(ODC; 200-800 mg/kg, s.c.), to rats has no detectable behavioral effects using a battery of tests to assess sensorimotor function. In contrast, the induction of
tremor
by chlordecone, a neurotoxic agent that affects neuronal ionic processes, is significantly attenuated by pretreatment with DFMO. The effects of DFMO on chlordecone-induced
tremor
were reversed by pretreatment with putrescine. DFMO had no effects on p,p'-DDT, a tremorigen having a mechanism of action different from chlordecone. These findings imply that polyamines may play a role in select neuronal processes.
...
PMID:Inhibition of ornithine decarboxylase alters neurological responsiveness to a tremorigen. 242 59
By the use of an in vivo assay,
ornithine decarboxylase
(
L-ornithine carboxy-lyase
,
EC 4.1.1.17
) is shown to be developmentally regulated in Dictyostelium discoideum. High levels of cAMP can induce
ornithine decarboxylase
activity in preaggregative cells kept in
shaking
suspension, under similar conditions as where other markers for development can also be induced. This induction by cAMP is solely dependent on the total amount of cAMP to which the cells have been exposed, and not on the manner of cAMP addition. Induction of
ornithine decarboxylase
activity, when measured in vitro, is caused by both an increase in total enzyme activity and by a proportional increase in activity of the high-affinity form for the cofactor pyridoxal phosphate. When measured in vivo, an additional regulatory mechanism seems to be involved. Kinetic studies with the competitive inhibitor putrescine suggest that in cAMP-stimulated cells the low affinity form of the enzyme may also be active in vivo.
...
PMID:The developmental regulation of L-ornithine decarboxylase in Dictyostelium discoideum and its induction by cAMP. 299 May 80
A sensitive chemiluminescence-based method for the assay of
ornithine decarboxylase
(
ODC
) has been developed. This method, which permits the detection of putrescine (the product of
ODC
) at a picomolar range, can be used to determine
ODC
activity in cellular extracts. Extracts are incubated with ornithine and spotted onto p81 phosphocellulose paper strips. After drying, the papers are washed with ammonium hydroxide to remove contaminants, which may interfere with the assay. Putrescine is next eluted from the paper by
shaking
in an elution buffer containing magnesium sulfate. Partially purified hog kidney diamine oxidase is then used to oxidize putrescine in the eluate. The hydrogen peroxide formed during the oxidation is determined by chemiluminescence using luminol and peroxidase. This simple analytical method has the sensitivity of conventional assays based on the use of radioactive ornithine.
...
PMID:A luminescence-based test for determining ornithine decarboxylase activity. 1111 77